Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Results of the 2025 AMWA Generative AI Member Survey
0
Zitationen
12
Autoren
2026
Jahr
Abstract
Generative artificial intelligence (GenAI) is rapidly transforming medical communication, offering new tools for content creation, summarization, and editing. Although GenAI-assisted writing presents both opportunities and risks, data on how medical communicators are adopting these technologies are limited. To address this limitation, AMWA formed an AI Task Force in 2025 and conducted a survey to understand the current knowledge, experience, and needs of the AMWA membership with respect to GenAI technology. This article presents the survey’s findings, first shared at AMWA’s 2025 Medical Writing & Communication Conference in November. The responses will inform recommendations by the AI Task Force to the Board of Directors on initiatives to support members’ understanding and use of GenAI in medical communication.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.316 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.177 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.575 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.776 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.468 Zit.
Autoren
Institutionen
- The Task Force for Global Health(US)
- Foundation for Physical Medicine and Rehabilitation(US)
- ResearchWorks (United States)(US)
- CTS Forex (Canada)(CA)
- Certis USA (United States)(US)
- Medline (United States)(US)
- Johnson & Johnson (United States)(US)
- Johnson & Johnson (Canada)(CA)
- Regeneron (United States)(US)
- Underground Systems (United States)(US)
- Xi'an Peihua University(CN)
- Springer Nature (Germany)(DE)
- Pfizer (United States)(US)